130 related articles for article (PubMed ID: 2946208)
1. [Treatment of advanced cancer of the prostate using LHRH analogs. How can a possible initial flare-up be prevented?].
Bouffioux C; Denis L; Mahler C; de Leval J
Acta Urol Belg; 1986; 54(3):304-8. PubMed ID: 2946208
[No Abstract] [Full Text] [Related]
2. Treatment of advanced carcinoma of the prostate by LHRH-agonists.
Claes HI; Vandenbussche L; Vereecken RL
Prog Clin Biol Res; 1987; 243A():229-37. PubMed ID: 2958853
[No Abstract] [Full Text] [Related]
3. Combined treatment (goserelin plus flutamide) versus monotherapy (goserelin alone) in advanced prostate cancer: a randomized study.
Jurincic CD; Horlbeck R; Klippel KF
Semin Oncol; 1991 Oct; 18(5 Suppl 6):21-5. PubMed ID: 1835139
[TBL] [Abstract][Full Text] [Related]
4. [LHRH analogs--new possibilities in the treatment of prostatic cancer].
Baranowska B
Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1009-12. PubMed ID: 6239145
[No Abstract] [Full Text] [Related]
5. [Treatment of carcinoma of the prostate with analogs of LHRH].
Rubio Herrera MA; Calle Fernández JR
Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
[No Abstract] [Full Text] [Related]
6. Treatment of advanced prostatic cancer with LHRH-analogues. Prevention of "flare-up" phenomenon.
Bouffioux C; Denis L; Mahler C; de Leval J
Prog Clin Biol Res; 1987; 243A():255-60. PubMed ID: 2958857
[No Abstract] [Full Text] [Related]
7. Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
Tunn UW; Goldschmidt AJ; Peter K; Becker M
Prog Clin Biol Res; 1990; 359():165-76; discussion 177-80. PubMed ID: 2149458
[No Abstract] [Full Text] [Related]
8. Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study.
Di Silverio F; Serio M; D'Eramo G; Sciarra F
Eur Urol; 1990; 18 Suppl 3():54-61. PubMed ID: 2151278
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Moffat LE
Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272
[No Abstract] [Full Text] [Related]
10. Use of the LHRH analogue zoladex depot alone and in combination with cyproterone acetate in the treatment of advanced prostatic cancer.
Di Silverio F; Serio M; Costantini A
J Chemother; 1989 Jul; 1(4 Suppl):1231-4. PubMed ID: 16312846
[No Abstract] [Full Text] [Related]
11. Simultaneous administration of a luteinizing hormone releasing hormone agonist and diethylstilbestrol in the initial treatment of prostatic cancer.
Mahler C; Denis L
Am J Clin Oncol; 1988; 11 Suppl 2():S127-8. PubMed ID: 2977268
[TBL] [Abstract][Full Text] [Related]
12. A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study.
Emtage LA; Trethowan C; Kelly K; Arkell D; Wallace DM; Hughes M; Hay A; Blacklock R; Jones M; Rouse A
Prog Clin Biol Res; 1989; 303():47-52. PubMed ID: 2528739
[No Abstract] [Full Text] [Related]
13. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
Banchini A; Zavaroni D; Tarditi E; Cortellini P; Ziveri M; Polotti R; Stefani F; Valenti G
Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662
[TBL] [Abstract][Full Text] [Related]
14. LHRH-analogues therapy for metastatic prostate cancer.
Debruyne FM; Fernandez del Moral P; Geboers AD
Prog Clin Biol Res; 1988; 260():27-39. PubMed ID: 2966406
[No Abstract] [Full Text] [Related]
15. Testicular changes after treatment with a GnRH analog (buserelin) in association with cyproterone acetate in men with prostatic cancer.
Properzi G; Francavilla S; Vicentini C; Cordeschi G; Galassi P; Paradiso Galatioto G; Miano L
Eur Urol; 1989; 16(6):426-32. PubMed ID: 2531668
[TBL] [Abstract][Full Text] [Related]
16. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
[No Abstract] [Full Text] [Related]
17. Endocrine therapy for advanced stage D prostate cancer.
Taylor TK
Urol Nurs; 1991 Sep; 11(3):22-6. PubMed ID: 1833823
[No Abstract] [Full Text] [Related]
18. LH-RH analogue treatment of advanced prostatic cancer.
Alcini E; D'Addessi A; Vacilotto D
Prog Clin Biol Res; 1987; 243A():243-4. PubMed ID: 2958854
[No Abstract] [Full Text] [Related]
19. Goserelin--another LH-RH analog for prostate cancer.
Med Lett Drugs Ther; 1990 Nov; 32(830):102. PubMed ID: 1700261
[No Abstract] [Full Text] [Related]
20. The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Allen JM; Williams G; O'Shea JP; Smith C; Yeo T; Kerle D; Bloom SR
Urol Res; 1984; 12(5):249-51. PubMed ID: 6240150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
